Nurix Therapeutics, Inc. Annual Revenues in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Nurix Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2019 to 2023.
  • Nurix Therapeutics, Inc. Revenues for the quarter ending February 29, 2024 was $16.6M, a 30.7% increase year-over-year.
  • Nurix Therapeutics, Inc. Revenues for the twelve months ending February 29, 2024 was $80.9M, a 94% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Revenues for 2023 was $77M, a 99.3% increase from 2022.
  • Nurix Therapeutics, Inc. annual Revenues for 2022 was $38.6M, a 29.8% increase from 2021.
  • Nurix Therapeutics, Inc. annual Revenues for 2021 was $29.8M, a 66.9% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $77M +$38.4M +99.3% Dec 1, 2022 Nov 30, 2023 10-K 2024-02-15
2022 $38.6M +$8.88M +29.8% Dec 1, 2021 Nov 30, 2022 10-K 2024-02-15
2021 $29.8M +$11.9M +66.9% Dec 1, 2020 Nov 30, 2021 10-K 2023-02-09
2020 $17.8M -$13.3M -42.7% Dec 1, 2019 Nov 30, 2020 10-K 2022-01-28
2019 $31.1M Dec 1, 2018 Nov 30, 2019 10-K 2022-01-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.